160 related articles for article (PubMed ID: 11339972)
1. How does pindolol improve antidepressant action?
Artigas F; Celada P; Laruelle M; Adell A
Trends Pharmacol Sci; 2001 May; 22(5):224-8. PubMed ID: 11339972
[TBL] [Abstract][Full Text] [Related]
2. Is the beneficial antidepressant effect of coadministration of pindolol really due to somatodendritic autoreceptor antagonism?
Cremers TI; Wiersma LJ; Bosker FJ; den Boer JA; Westerink BH; Wikström HV
Biol Psychiatry; 2001 Jul; 50(1):13-21. PubMed ID: 11457419
[TBL] [Abstract][Full Text] [Related]
3. Effects of (-)-tertatolol, (-)-penbutolol and (+/-)-pindolol in combination with paroxetine on presynaptic 5-HT function: an in vivo microdialysis and electrophysiological study.
Gartside SE; Clifford EM; Cowen PJ; Sharp T
Br J Pharmacol; 1999 May; 127(1):145-52. PubMed ID: 10369467
[TBL] [Abstract][Full Text] [Related]
4. Selective activation of postsynaptic 5-HT1A receptors induces rapid antidepressant response.
Blier P; Bergeron R; de Montigny C
Neuropsychopharmacology; 1997 May; 16(5):333-8. PubMed ID: 9109104
[TBL] [Abstract][Full Text] [Related]
5. 5-HT(1A) agonist potential of pindolol: electrophysiologic studies in the dorsal raphe nucleus and hippocampus.
Sprouse J; Braselton J; Reynolds L
Biol Psychiatry; 2000 Jun; 47(12):1050-5. PubMed ID: 10862804
[TBL] [Abstract][Full Text] [Related]
6. Differential occupancy of somatodendritic and postsynaptic 5HT(1A) receptors by pindolol: a dose-occupancy study with [11C]WAY 100635 and positron emission tomography in humans.
Martinez D; Hwang D; Mawlawi O; Slifstein M; Kent J; Simpson N; Parsey RV; Hashimoto T; Huang Y; Shinn A; Van Heertum R; Abi-Dargham A; Caltabiano S; Malizia A; Cowley H; Mann JJ; Laruelle M
Neuropsychopharmacology; 2001 Mar; 24(3):209-29. PubMed ID: 11166513
[TBL] [Abstract][Full Text] [Related]
7. An index of 5-HT synthesis changes during early antidepressant treatment: alpha-[11C]methyl-L-tryptophan PET study.
Berney A; Nishikawa M; Benkelfat C; Debonnel G; Gobbi G; Diksic M
Neurochem Int; 2008; 52(4-5):701-8. PubMed ID: 17928105
[TBL] [Abstract][Full Text] [Related]
8. The use of pindolol to potentiate antidepressant medication.
Blier P; Bergeron R
J Clin Psychiatry; 1998; 59 Suppl 5():16-23; discussion 24-5. PubMed ID: 9635544
[TBL] [Abstract][Full Text] [Related]
9. Pindolol, a beta-adrenoceptor blocker/5-hydroxytryptamine(1A/1B) antagonist, enhances the analgesic effect of tramadol.
Rojas-Corrales OM; Ortega-Alvaro A; Gibert-Rahola J; Roca-Vinardell A; Micó JA
Pain; 2000 Nov; 88(2):119-124. PubMed ID: 11050366
[TBL] [Abstract][Full Text] [Related]
10. Combining pindolol and paroxetine in an animal model of chronic antidepressant action--can early onset of action be detected?
Cryan JF; McGrath C; Leonard BE; Norman TR
Eur J Pharmacol; 1998 Jul; 352(1):23-8. PubMed ID: 9718263
[TBL] [Abstract][Full Text] [Related]
11. Pindolol suppresses serotonergic neuronal activity and does not block the inhibition of serotonergic neurons produced by 8-hydroxy-2-(di-n-propylamino)tetralin in awake cats.
Fornal CA; Martin FJ; Metzler CW; Jacobs BL
J Pharmacol Exp Ther; 1999 Oct; 291(1):229-38. PubMed ID: 10490909
[TBL] [Abstract][Full Text] [Related]
12. EEG effects of buspirone and pindolol: a method of examining 5-HT1A receptor function in humans.
McAllister-Williams RH; Massey AE
Psychopharmacology (Berl); 2003 Mar; 166(3):284-93. PubMed ID: 12589521
[TBL] [Abstract][Full Text] [Related]
13. An autoradiographic study of the influence of pindolol upon [35S]GTPgammaS binding in rat, guinea pig and human brain.
Serrats J; Artigas F; Mengod G; Cortés R
Int J Neuropsychopharmacol; 2004 Mar; 7(1):27-34. PubMed ID: 14720318
[TBL] [Abstract][Full Text] [Related]
14. [Interest of the use of pindolol in the treatment of depression: review].
Brousse G; Schmitt A; Chereau I; Eschalier A; Dubray C; Llorca PM
Encephale; 2003; 29(4 Pt 1):338-50. PubMed ID: 14615704
[TBL] [Abstract][Full Text] [Related]
15. The augmentation hypothesis for improvement of antidepressant therapy: is pindolol a suitable candidate for testing the ability of 5HT1A receptor antagonists to enhance SSRI efficacy and onset latency?
Kinney GG; Taber MT; Gribkoff VK
Mol Neurobiol; 2000 Jun; 21(3):137-52. PubMed ID: 11379796
[TBL] [Abstract][Full Text] [Related]
16. The effect of ipsapirone and S(-)-pindolol on dopamine release in rat striatum and nucleus accumbens.
Ichikawa J; Meltzer HY
Brain Res; 1999 Sep; 842(2):445-51. PubMed ID: 10526141
[TBL] [Abstract][Full Text] [Related]
17. beta-blocker binding to human 5-HT(1A) receptors in vivo and in vitro: implications for antidepressant therapy.
Rabiner EA; Gunn RN; Castro ME; Sargent PA; Cowen PJ; Koepp MJ; Meyer JH; Bench CJ; Harrison PJ; Pazos A; Sharp T; Grasby PM
Neuropsychopharmacology; 2000 Sep; 23(3):285-93. PubMed ID: 10942852
[TBL] [Abstract][Full Text] [Related]
18. Effects of sustained (+/-)pindolol administration on serotonin neurotransmission in rats.
Haddjeri N; Blier P
J Psychiatry Neurosci; 2000 Sep; 25(4):378-88. PubMed ID: 11022403
[TBL] [Abstract][Full Text] [Related]
19. Is pindolol a mixed agonist-antagonist at central serotonin (5-HT) receptors?
Hjorth S; Carlsson A
Eur J Pharmacol; 1986 Sep; 129(1-2):131-8. PubMed ID: 2429847
[TBL] [Abstract][Full Text] [Related]
20. Positron emission tomography study of pindolol occupancy of 5-HT(1A) receptors in humans: preliminary analyses.
Martinez D; Mawlawi O; Hwang DR; Kent J; Simpson N; Parsey RV; Hashimoto T; Slifstein M; Huang Y; Van Heertum R; Abi-Dargham A; Caltabiano S; Malizia A; Cowley H; Mann JJ; Laruelle M
Nucl Med Biol; 2000 Jul; 27(5):523-7. PubMed ID: 10962261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
